CCRM’s business development team provides consulting services for business planning, market intelligence, and regulatory and intellectual property (IP) strategy to customers in industry and academia.
With over 1,000 consultation hours and more than 300 technology reviews under our belt, our commercialization and technology expertise will enable you to streamline the processes required to bring your technologies toward target markets.
Specific Areas of Expertise:
- Regulatory affairs consultation with staff that have 10+ years of experience within Health Canada, navigating both Canadian and international regulatory policies for cell and gene therapy
- Product classification, transplant registration and Health Canada regulatory interaction and submission services
- Technology reviews, including data review
- Market assessment of novel technologies
- Competitive landscape analysis from both IP and market perspectives
- Patent strategy
- Defining appropriate commercial paths
CCRM’s Incubation Program:
CCRM has developed a model for incubating new companies that we believe will improve their chances for long-term success. We create new companies based on innovations that address unmet market opportunities in regenerative medicine. Our program de-risks the technology by leveraging our expertise and infrastructure and bundles the technology with other innovations or strategic partners to develop next-generation gene and cell therapies. With access to CCRM’s growing entrepreneur and investor networks, we accelerate new company concepts towards a successful launch and external investment.
We also offer extensive support to our incubation companies when they graduate from the program as an independent venture. This may include financial modeling, back-office, intellectual property and regulatory support, in addition to technical expertise and use of our development laboratories at preferred rates.
If you have a technology that could be a candidate for our unique company creation program, please email email@example.com.
“As the Regenerative Medicine arm of Medcan is relatively new, we were interested in gaining a deeper understanding of the market opportunities open to us. We engaged CCRM to prepare an overview of the current regenerative medicine landscape and future directions of the field. CCRM provided us with a personalized market report covering our areas of interest and answered any questions we had regarding the findings in relation to our goals. CCRM’s services and expertise were of high value to us and we look forward to potential collaborations in the future.”
Rob Francis, Vice President, Business Development – Regenerative Medicine, Medcan
For more information, please contact us at: